West Pharmaceutical Services (WST) Current Leases (2019 - 2026)

West Pharmaceutical Services' Current Leases history runs 8 years deep, the most recent figure standing at $21.4 million for Q1 2026.

• In Q1 2026, Current Leases fell 1.83% year-over-year to $21.4 million; the TTM figure through Mar 2026 stood at $21.4 million (down 1.83% YoY), while the FY2025 annual figure was $22.7 million, up 26.82% from the prior year.
• Current Leases came in at $21.4 million for Q1 2026 at West Pharmaceutical Services, down from $22.7 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $22.7 million in Q4 2025 to a low of $9.8 million in Q1 2022.
• A 5-year average of $17.7 million and a median of $17.9 million in 2024 frame the typical range for Current Leases.
• Across the five-year window, Current Leases surged 72.04% in 2022 and fell 1.83% in 2026, its largest moves.
• West Pharmaceutical Services' Current Leases stood at $16.0 million in 2022, then gained by 10.62% to $17.7 million in 2023, then increased by 1.13% to $17.9 million in 2024, then grew by 26.82% to $22.7 million in 2025, then fell by 5.73% to $21.4 million in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $21.4 million, $22.7 million, and $21.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison